Coagulation and fibrinolysis abnormalities in obesity (Q35037271)

5 August 2017

1 reference

title

Coagulation and fibrinolysis abnormalities in obesity (English)

1 reference

5 August 2017

0 references

De Pergola G

1

1 reference

PubMed ID

12508953

5 August 2017

Pannacciulli N

series ordinal

2

1 reference

5 August 2017

1 November 2002

1 reference

Journal of Endocrinological Investigation

5 August 2017

1 reference

5 August 2017

25

1 reference

5 August 2017

899-904

1 reference

5 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03344054

5 August 2017

0 references

cites work

Health consequences of visceral obesity

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Fat cell function and fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

High levels of circulating proinflammatory cytokines and leptin in urban, but not rural, Indians. A potential explanation for increased risk of diabetes and coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

The effect of fish oil on hypertension, plasma lipids and hemostasis in hypertensive, obese, dyslipidemic patients with and without diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Influence of free testosterone on antigen levels of plasminogen activator inhibitor-1 in premonopausal women with central obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344054

Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity

21 January 2018

1 reference

12 December 2020

The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity

1 reference

12 December 2020

Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men

1 reference

12 December 2020

Regulation of plasminogen activitor inhibitor-1 in human adipose tissue: interaction between cytokines, cortisol and estrogen

1 reference

12 December 2020

Thrombophilia in Patients with Hypertriglyceridemia

1 reference

12 December 2020

Dietary treatment of thrombogenic disorders related to the metabolic syndrome

1 reference

12 December 2020

Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects

1 reference

12 December 2020

Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variables

1 reference

12 December 2020

Effect of leptin in platelet and endothelial cells. Obesity and arterial thrombosis

1 reference

12 December 2020

Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?

1 reference

12 December 2020

Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance

1 reference

12 December 2020

Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents

1 reference

12 December 2020

Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals

1 reference

12 December 2020

Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines

1 reference

12 December 2020

Effects of short-term energy restriction and physical training on haemostatic risk factors for coronary heart disease in obese children and adolescents

1 reference

12 December 2020

The fat mouse. A powerful genetic model to study hemostatic gene expression in obesity/NIDDM.

1 reference

12 December 2020

A family history of type 2 diabetes is associated with lower sensitivity to activated protein C in overweight and obese premenopausal women.

1 reference

12 December 2020

Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria

1 reference

12 December 2020

Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin-resistant mice and adipocytes.

1 reference

12 December 2020

Moderate genetic influences on plasma levels of plasminogen activator inhibitor-1 and evidence of genetic and environmental influences shared by plasminogen activator inhibitor-1, triglycerides, and body mass index

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03344054

1 reference

5 August 2017

1 reference

PubMed ID

12508953